THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 121 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $686 | -5.2% | 80,955 | +0.2% | 0.01% | -16.7% |
| Q1 2024 | $724 | -28.5% | 80,755 | -31.2% | 0.01% | -40.0% |
| Q3 2023 | $1,012 | -5.7% | 117,318 | +13.2% | 0.01% | +11.1% |
| Q2 2023 | $1,073 | -99.8% | 103,681 | +92.5% | 0.01% | +28.6% |
| Q1 2022 | $515,000 | +372.5% | 53,850 | +264.1% | 0.01% | +600.0% |
| Q3 2021 | $109,000 | -91.7% | 14,791 | -83.7% | 0.00% | -93.3% |
| Q2 2021 | $1,319,000 | +383.2% | 90,864 | +391.9% | 0.02% | +200.0% |
| Q3 2020 | $273,000 | -58.6% | 18,472 | -41.2% | 0.01% | -70.6% |
| Q2 2020 | $659,000 | – | 31,405 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 8,511,350 | $72,176,248 | 9.12% |
| Newtyn Management, LLC | 2,124,703 | $18,017,481 | 3.38% |
| Irenic Capital Management LP | 2,760,948 | $23,412,839 | 2.86% |
| Weiss Asset Management LP | 7,457,060 | $63,235,869 | 2.39% |
| Oasis Management Co Ltd. | 1,157,965 | $9,819,543 | 2.21% |
| Park West Asset Management LLC | 1,700,000 | $14,416,000 | 1.06% |
| Baupost Group | 4,200,021 | $35,616 | 0.98% |
| Camber Capital Management LP | 1,000,000 | $8,480 | 0.24% |
| Virtus ETF Advisers LLC | 38,386 | $325,513 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 204,089 | $1,731 | 0.12% |